Polydeoxyribonucleotide, commonly abbreviated as PDRN, is emerging as a notable ingredient in the skincare industry, particularly within Korean beauty (K-beauty) products. Its increasing presence in moisturizers, serums, and masks has fueled consumer interest due to claims that it promotes collagen synthesis, skin rejuvenation, and brighter complexions. However, experts urge caution in interpreting these claims, especially when comparing topical applications with injectable treatments.

PDRN consists of DNA fragments usually derived from salmon, which have been researched primarily for their wound healing and tissue repair properties. Among dermatologists, injectable forms of polynucleotides—including PDRN—have demonstrated significant clinical results. These treatments, popularized by endorsements from celebrities since 2023, involve direct injection into the dermis, allowing the compounds to interact intimately with skin cells and stimulate regeneration.

Despite promising outcomes from injectable PDRN, evidence supporting its effectiveness when applied topically remains limited. Dermatologist Dr. Anjali Mahto, founder of Self London, highlights that the biological benefits witnessed with injections do not necessarily translate to serums and creams. This distinction is important because topical formulations must penetrate the skin barrier differently and may not deliver equivalent results.

Some products containing PDRN have garnered positive attention, often due to the combination of this ingredient with other active compounds. For example, the Medik8 Exo-PDRN Prismatic+ Youthful Vitality Serum incorporates a vegan alternative to salmon-derived DNA fragments and includes peptides known for their skin-refreshing effects. This formulation is suggested to be beneficial for those concerned with fine lines and overall skin quality. Similarly, Anua’s PDRN Hyaluronic Acid 100 Moisturizing Cream combines PDRN with brightening agents, appealing to individuals managing dryness, pigmentation, or sun-induced damage.

While the science behind PDRN continues to evolve, aesthetic professionals describe injectable treatments as potentially activating skin cell function and promoting repair mechanisms. However, until further research confirms comparable efficacy in topical products, experts advise consumers to temper expectations and consider the full ingredient profile rather than focusing solely on the presence of PDRN.

Skincare professionals also note a shift away from aggressive formulations toward gentler, skin-friendly products, a trend influenced by K-beauty’s emphasis on nurturing the skin barrier. In this context, PDRN-containing products might serve as complementary additions within a broader, well-rounded regimen but are not yet recommended as standalone solutions based solely on their PDRN content.

In summary, PDRN offers an intriguing avenue in skin health research but remains a developing ingredient whose topical benefits require more substantiation. Consumers are encouraged to assess products critically and await further scientific validation before making significant investments based purely on current marketing claims.